No Data
Piper Upgrades Teleflex to Overweight, Cites Expected EPS Growth
This Medical Devices Stock Has Several Catalysts, Says Bullish Analyst
Teleflex Inc (NYSE:TFX) benefited in the first quarter from the surge in the interventional segment and other tailwinds.UroLift sales in the physician's office could bottom out at $49 million in 2024
Express News | Teleflex Shares up 3.6% After Piper Sandler Raises to Overweight From Neutral
Piper Sandler Upgrades Teleflex(TFX.US) to Buy Rating, Raises Target Price to $245
Piper Sandler analyst Matthew O'Brien upgrades $Teleflex(TFX.US)$ to a buy rating, and adjusts the target price from $205 to $245.According to TipRanks data, the analyst has a success rate of 51.1% an
Teleflex Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/01/2024 16.48% Piper Sandler $205 → $245 Upgrades Neutral → Overweight 05/03/2024 4.12% Truist Securiti
Express News | Teleflex Inc : Piper Sandler Raises to Overweight From Neutral; Raises Target Price to $245 From $205